Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D09OPS
|
|||
Former ID |
DIB007555
|
|||
Drug Name |
SN-28049
|
|||
Synonyms |
DNA-intercalating topoisomerase inhibitor (cancer), University of Auckland
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Solid tumour/cancer [ICD-11: 2A00-2F9Z; ICD-10: C76-C80; ICD-9: 140-229] | Investigative | [1] | |
Company |
University of Auckland
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H22N4O2
|
|||
Canonical SMILES |
CC1=C2C(=CC=C1)C=C3C(=N2)C(=CN(C3=O)C)C(=O)NCCN(C)C
|
|||
InChI |
1S/C19H22N4O2/c1-12-6-5-7-13-10-14-17(21-16(12)13)15(11-23(4)19(14)25)18(24)20-8-9-22(2)3/h5-7,10-11H,8-9H2,1-4H3,(H,20,24)
|
|||
InChIKey |
CSMRPIFORJZYCJ-UHFFFAOYSA-N
|
|||
CAS Number |
CAS 492472-30-7
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | The ChEMBL database in 2017. Nucleic Acids Res. 2017 Jan 4;45(D1):D945-D954. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.